StockWatch
·
Filing
Q4

HCL TECHNOLOGIES LTD.

HCLTECHFY2621 Apr 2026
Revenue+0.3%
Net Profit+10.0%
OPM19.75%

P&L

Quarterly Consolidated

Revenue
+0.3%34.0K
Expenditure
+2.9%28.6K
Net Profit
+10.0%4.5K
NPM 13.09%+9.8%EPS ₹16.59+10.2%

vs Q3 FY26

HCLTech FY26 Revenue ₹130,144 Cr, NI ₹17,361 Cr; Guides FY27

21 Apr 2026 · 21 Apr, 6:12 pm

Summary

HCLTech announced its Q4 and full-year FY2026 financial results, with full-year INR revenue climbing to ₹130,144 Crores, marking an 11.2% increase, though net income saw a slight dip of 0.2% to ₹17,361 Crores. Q4 FY2026 performance included INR revenue of ₹33,981 Crores, up 12.3% year-on-year, and net income growing by 4.2% year-on-year to ₹4,488 Crores. The company demonstrated strong business momentum with total contract value from new deal wins reaching $9,323M for the fiscal year. Looking ahead, HCLTech issued FY2027 guidance projecting company revenue growth between 1.0% and 4.0% in constant currency, along with an EBIT margin forecast of 17.5% to 18.5%.

Key Highlights

  1. 1

    HCLTech reported full-year FY2026 INR Revenue of ₹130,144 Crores, reflecting an 11.2% year-on-year increase.

  2. 2

    Constant Currency (CC) Revenue for FY2026 grew by 3.9%, with HCLTech Services CC Revenue increasing by 4.8%.

  3. 3

    Net Income for FY2026 stood at ₹17,361 Crores (13.3% of revenue), experiencing a marginal decrease of 0.2% year-on-year.

  4. 4

    Total Contract Value (TCV) for new deal wins reached $9,323M for the full fiscal year 2026.

  5. 5

    For Q4 FY2026, INR Revenue was ₹33,981 Crores, growing by 12.3% year-on-year, while Net Income increased by 4.2% year-on-year to ₹4,488 Crores.

  6. 6

    The company's LTM attrition improved to 12.5% in FY2026, down from 13.0% in Q4 of the prior year, with a net addition of 3,761 people.

  7. 7

    HCLTech provided FY2027 guidance expecting Company Revenue growth between 1.0% - 4.0% YoY in Constant Currency and an EBIT margin of 17.5% – 18.5%.

Informational and educational content only. Not investment advice.